Article information
Full text is only aviable in PDF
References
[1.]
CAPRIE Steering Committee.
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE).
Lancet, 348 (1996), pp. 1329-1339
[2.]
P.K. Kilaru, M.J. Schweiger, H.A. Kozman, T.R. Weil.
Diffuse alveolar hemorraghe after clopidogrel use.
J Invasive Cardiol, 13 (2001), pp. 535-537
[3.]
D.S. Gill, K. Ng, K.S. Ng.
Massive pulmonary haemorrhage complicating the treatment of acute coronary syndrome.
Heart, 90 (2004), pp. e15
[4.]
M. Haro, L.A. Álvarez, X. Baldó, A. Palos, M. Rubio, M. Rubio.
Hemotórax bilateral secundario al tratamiento antiagregante con clopidogrel y ácido acetilsalicílico.
Arch Bronconeumol, 42 (2006), pp. 307-309
[5.]
G. Kocabay, I. Okçular, V. Acalla, K. Güler.
Suicide attempt with clopidogrel.
Hum Exper Toxicol, 25 (2006), pp. 731-734
[6.]
H.C. Diener, J. Bogoulavssky, L.M. Bras, C. Cimminiello, L. Csiba, M. Kaste, et al.
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomized, doubleblind, placebo-controlled trial.
Lancet, 364 (2004), pp. 331-337
Copyright © 2009. Sociedad Española de Neumología y Cirugía Torácica
